Study of Denosumab in Subjects With Giant Cell Tumor of Bone

Clinical trial NCT00680992 · COMPLETED

Trial details

NCT number: NCT00680992
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer Giant Cell Tumors Giant Cell Tumor of Bone Benign Giant Cell Tumors

Start date: 2008-09-09
Primary completion: 2018-05-17
Enrollment: 535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.